1. Cook N, Shepherd A, Dunleavy S, et al. Essentials of Pathophysiology for Nursing Practice. SAGE Publications; 2022.
2.
Levey AS. Defining AKD: the spectrum of AKI, AKD, and CKD. Nephron 2022; 146(3): 302–305, doi: 10.1159/000516647.
3.
Freiz MM, Mohamed AA, Mousa YI. Biomarkers for Acute Kidney Injury. Minia Journal of Medical Research 2020; 31(4): 46–49.
4.
Gupta B, Tiwari P, Subramanian A, et al. Evaluation of plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) as an early diagnostic marker of acute kidney injury (AKI) in critically ill trauma patients. J Anaesthesiol Clin Pharmacol 2023; 39(2): 292–301, doi: 10.4103/joacp.joacp_284_21.
5.
Mahryar M, Barekatain B, Gheisari A, et al. Serum KIM-1 and Cystatin Levels as the Predictors of Acute Kidney Injury in Asphyxiated Neonates. IJN 2022; 13(1): 6–12, doi: 10.22038/IJN.2021.58428.2126.
6.
Brilland B, Boud’hors C, Wacrenier S, et al. Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis. Clin Kidney J 2023; 16(9): 1521–1533, doi: 10.1093/ckj/sfad071.
7.
Gohda T, Kamei N, Koshida T, et al. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease. J Diabetes Investig 2020; 11(2): 435–440, doi: 10.1111/jdi.13139.
8.
Aljorani RH, Saleh ES, Al Mohammadawi KGH. Correlation of Kidney Injury Molecule-1 and Nephrin Levels in Iraqi Patients with Diabetic Nephropathy. Al-Rafidain Journal of Medical Sciences 2023; 5: 99–104, doi: 10.54133/ajms.v5i.167.
9.
Marakala V. Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury – A systematic review. Clinica Chimica Acta 2022; 536: 135–141, doi: 10.1016/j.cca.2022.08.029.
10.
Naqvi R, Hossain N, Butt S, et al. Efficacy of multiple Biomarkers: NGAL, KIM1, Cystatin C and IL18 in predicting pregnancy-related acute kidney injury. Pakistan Journal of Medical Sciences 2023; 39(1): 34, doi: 10.12669/pjms.39.1.6930.
11.
Kaddam LA, Kaddam AS. Effect of Gum Arabic (Acacia Senegal) on C-reactive protein level among sickle cell anemia patients. BMC Research Notes 2020; 13(1): 1–5, doi: 10.1186/s13104-020-05016-2.
12.
Abed HH, Al-Ziaydi AG, Taher IA, et al. Comparison of Some Hematological Parameters between Male and Female Patients Infected with COVID-19. Human Antibodies 2022; 30(3): 151–155, doi: 10.3233/HAB-220006.
13.
Simsek B, Cinar T, Inan D, et al. C-reactive protein/albumin ratio predicts acute kidney injury in patients with moderate to severe chronic kidney disease and non-ST-segment elevation myocardial infarction. Angiology 2022; 73(2): 132–138, doi: 10.1177/00033197211029093.
14.
Salvador CL. Estimation and measurement of glomerular filtration rate in children 2020 [Doctoral thesis]. Oslo: Department of Medical Biochemistry, Institute of Clinical Medicine, Faculty of Medicine University of Oslo; 2019. Available from URL: http://urn.nb.no/URN:NBN:no-78526.
15.
Schellack N, Naested C, Sandt van der, N, et al. Management of urinary tract infections in children. SAFP 2017; 59(6); 16–20, doi: 10.4102/safp.v59i6.4772.
16.
Kocadal K, Ozseker PE, Ceylanli D, et al. Exposure and risk assessment of glyphosate-based herbicide among farmers in northern Cyprus: a pilot study. Applied Ecology & Environmental Research 2023; 21(4): 3679–3689, doi: 10.15666/aeer/2104_36753689.
17.
Schwartz GJ, Schneider MF, Maier PS, et al. Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 2012; 82(4): 445–453.
18.
Al-Shibli RH, Yousif Al-Fatlawi AC, Jaafar AQ. Evaluation of some Biomarkers Adiponectin, Troponin, and C-reactive protein (CRP) for Atherosclerosis Obese and non-obese patients and related with oxidation, antioxidation parameters in Kerbala Governorate. Journal of Advanced Zoology 2023; 44.
19.
Waheed YA, Al-Shireefy HM. Incidence of acute kidney injury in hospitalized COVID-19 patients. Medical Journal of Babylon 2022; 19(4): 589–594.
20.
Luft FC. Biomarkers and predicting acute kidney injury. Acta Physiol (Oxf) 2021; 231(1): e13479, doi: 10.1111/apha.13479.
21.
Srisawat N, Kellum JA. The Role of Biomarkers in Acute Kidney Injury. Critical Care Clinics 2020; 36: 125–140.
22.
Menez S, Parikh CR. Assessing the health of the nephron in acute kidney injury: biomarkers of kidney function and injury. Curr Opin Nephrol Hypertens 2019; 28: 560–566.
23.
Capelli I, Vitali F, Zappulo F, et al. Biomarkers of kidney injury in very-low-birth-weight preterm infants: Influence of maternal and neonatal factors. In Vivo 2020; 34(3): 1333–1339; doi: 10.21873/invivo.11910.
24.
Rashid ZA, Ali BM, Azat NF. Assessment of Nutritional Status and Growth in Children with End Stage Renal Disease Undergoing Maintenance Hemodialysis: A Multicenter Study. Iraqi JMS 2023; 21(1), doi: 10.22578/IJMS.21.1.7.
25.
Noman Salman M, Jasim Kzar A, Hamzah AS. Determination of Cystatin C Level in a Sample of Patients with Chronic Kidney Disease. Journal of Techniques 2022; 4: 7–11, doi: 10.51173/jt.v4i33.520.
26.
Elsawy S, Nabiel A, Mohamed MM, et al. Is urinary kim-1 a better biomarker than its serum value in the diagnosis of Acute Kidney Injury disease? Medicine Updates 2020; 1(1): 55–67.
27.
Bjornstad EC, Muronya W, Smith ZH, et al. Saliva urea nitrogen dipsticks to predict acute kidney injury in Malawian trauma patients. African Journal of Nephrology 2023; 26(1), doi: 10.21804/26-1-5462 (2023).
28.
Nehomar PG. Biomarkers in acute kidney injury. J Clin Nephrol 2020; 4(2): 27–35, doi: 10.29328/journal.jcn.1001056.
29.
Delgado C, Baweja M, Crews DC, et al. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. Am J Kidney Dis 2022; 79(2): 268–288.e1, doi: 10.1053/j.ajkd.2021.08.003.
30.
Shahrin L, Sarmin M, Rahman AS, et al. Clinical and laboratory characteristics of acute kidney injury in infants with diarrhea: a cross-sectional study in Bangladesh. J Int Med Res 2020; 48(1): 300060519896913, doi: 10.1177/0300060519896913.
31.
Rein JL, Coca SG. “I don’t get no respect”: the role of chloride in acute kidney injury. Am J Physiol 2019; 316(3): F587–F605.
32.
Nogueira GM, Silva NLOR, Moura AF, et al. Acute kidney injury and electrolyte disorders in COVID-19. World J Virol 2022; 11(5): 283–292, doi: 10.5501/wjv.v11.i5.283.
33.
Fazel M, Sarveazad A, Ali KM, et al. Accuracy of urine kidney injury molecule-1 in predicting acute kidney injury in children; a systematic review and meta-analysis. Arch Acad Emerg Med 2020; 8(1): e44.
34.
Kadhim SH, Ubaid MM, Alboaklah HK. New biomarkers for diagnosing and treatment of kidney failure disease. Karbala Journal of Pharmaceutical Sciences 2022; 1(20).
35.
Li C, Xu L, Guan C, et al. Malnutrition screening and acute kidney injury in hospitalized patients: A retrospective study over 5 years from China. Br J Nutr 2020; 123(3): 337–346, doi: 10.1017/S000711451900271X.
36.
Whitehead SJ, Chadwick K, Ford C, et al. Comparative evaluation of two NGAL automated immunoassays in urine and plasma. J Appl Lab Med 2022; 7(3): 747–761, doi: 10.1093/jalm/jfab167.
37.
Wang J, Yang B, Liu M, et al. Serum cystatin C is a potential predictor of short-term mortality and acute kidney injury in acute aortic dissection patients: a retrospective cohort study. J Thorac Dis 2022; 14(8): 2977–2986, doi: 10.21037/jtd-22-937.
38.
Al-Fatlawi ACY. Evaluation of leptin serum concentration in cases of blood transfusion dependent Beta thalassemia and its relationship with thyroid dysfunction. Biomedicine 2022; 42(5): 1029–1033.